Articles related to Oncology, Radiation

“MB” is a frail, wheelchair-ridden, nearly blind, and mostly deaf woman living with early dementia and neglected lung cancer. What this oncologist thought MB wanted and needed was a lot different than what MB actually wanted and needed after discussing various options with her and talking to her family on numerous occasions. A humbling, honest view of an oncologist’s biases.

DLBCL is increasingly being recognized as a heterogeneous disease with distinct molecular subtypes. This has challenged the rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) treatment paradigm in recent years, as several DLBCL subtypes have inferior survival after standard R-CHOP therapy. So how do you choose? In this review the authors conclude with proposed clinical management scenarios in which DA-R-EPOCH may be preferred, including some for patient populations in which the use of R-CHOP vs. DA-R-EPOCH is controversial.

A study published in Morbidity & Mortality Weekly Report (MMWR) argues that immunosuppressed patients and people with compromised immune systems need more than two vaccine doses to achieve adequate protection against COVID-19. After two vaccine doses, immunocompromised patients saw 77% vaccine effectiveness against hospitalization, versus 90% for immunocompetent individuals.

The Journal of Clinical Oncology has a heartfelt account of one family’s struggle to access medical records after the death of a child from a brain tumor. Closing down online access to medical records is a common practice at hospitals and healthcare clinics following the death of a patient, often to the pain of family members who still have questions and seek answers.

You want speedy access to comprehensive records. Clinical decision-making tools. Optimized communication and data exchange. EHRs should be as unique as you, so whether you’re looking to replace or implement your first, this list can get you started.

Although the 2020 numbers will likely look MUCH different, the Merritt Hawkins survey from 2019 showed increased gains from previous years. Of the 62 responses representing 93 hospitals, cardiovascular surgery drove the most revenue. Still, the outlook remains bleak post-pandemic.